**Abstract**

**Objective**: Our pilot study showed that 5-HT1A receptor mainly contributed to DM-induced serotonin syndrome in mice. Earlier reports suggested that 5-HT1A receptor can activate protein kinase C (PKC) *in vitro*. In the present study, we investigated whether the up-regulation of 5-HT1A receptor induced by DM requires specific induction of PKC isoform.

**Methods**: Mice were pretreated with rottlerin, a pharmacological inhibitor of PKC-δ, 30 min before DM administration. Scores of serotonin syndrome (i.e. reciprocal forepaw treading, lateral head-weaving, hind-limb abduction, tremor, Straub tail and flat body posture) were assessed during 30 min after DM. In addition, rectal temperature was measured 30 min after DM. Serotonin levels and 5-HT1A receptor mRNA expression were examined in the hypothalamus 2 h after DM.

**Results**: A high dose of DM resulted in a specific induction of PKC-δ out of PKC-α, PKC-β1, PKC-β2, PKC-ξ, PKC-δ in the hypothalamus of mice. Rottlerin significantly attenuated serotonergic behaviors induced by DM. In addition, rottlerin protected increases in 5-HT1A receptor mRNA expression and serotonin level induced by DM in wild-type mice. Consistently, genetic inhibition of PKC-δ protected serotonergic behaviors and increases in serotonin level, mRNA expression of 5-HT1A receptor induced by DM.

**Conclusion**: Endogenous PKC-δ gene mediates serotonin syndrome induced by DM in mice \[This study was supported by a grant (14182MFDS979) from the Korea Food and Drug Administration, Republic of Korea\].
